PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,000 | -73.5% | 19,479 | -75.1% | 0.00% | -50.0% |
| Q1 2019 | $34,000 | +17.2% | 78,174 | -14.9% | 0.00% | 0.0% |
| Q4 2018 | $29,000 | -37.0% | 91,862 | +44.4% | 0.00% | -33.3% |
| Q3 2018 | $46,000 | +360.0% | 63,626 | +180.4% | 0.00% | – |
| Q2 2018 | $10,000 | -58.3% | 22,691 | -37.0% | 0.00% | -100.0% |
| Q4 2017 | $24,000 | +41.2% | 35,994 | +22.2% | 0.00% | 0.0% |
| Q3 2017 | $17,000 | – | 29,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,178,440 | $5,338,000 | 5.83% |
| GREAT POINT PARTNERS LLC | 399,007 | $1,808,000 | 1.25% |
| Camber Capital Management LP | 1,790,000 | $8,109,000 | 0.85% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,041,078 | $4,716,000 | 0.43% |
| FEDERATED HERMES, INC. | 10,427,472 | $47,237,000 | 0.18% |
| SILVERBACK ASSET MANAGEMENT LLC | 272,200 | $1,233,000 | 0.10% |
| Catalyst Capital Advisors LLC | 30,000 | $136,000 | 0.07% |
| OBERWEIS ASSET MANAGEMENT INC/ | 54,200 | $246,000 | 0.07% |
| Baillie Gifford | 5,548,351 | $25,134,000 | 0.06% |
| Fore Research & Management, LP | 200,000 | $906,000 | 0.06% |